Ā | Referred, % (95Ā % CI) | SCD detected, n | Missed SCDb, n | Accuracy for SCD | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Diagnostic model SCD probability threshold | Total | CRC | IBD | D | AA | Sensitivity, % (95Ā % CI) | PPV, % (95Ā % CI) | Specificity, % (95Ā % CI) | NPV, % (95Ā % CI) | ||
Basic | |||||||||||
āā„2.5Ā % | 98.0 (96.4ā99.2) | 141 | 0 | ā | ā | ā | ā | 99.7 (96.7ā100.0) | 17.7 (15.2ā20.5) | 2.3 (1.0ā4.1) | 98.0 (76.5ā100.0) |
āā„5.0Ā % | 86.9 (83.9ā89.6) | 136 | 5 | ā | ā | 2 | 3 | 97.0 (92.6ā98.8) | 19.4 (16.6ā22.5) | 15.2 (12.1ā18.8) | 95.9 (90.2ā98.5) |
āā„7.5Ā % | 72.5 (69.1ā75.6) | 126 | 15 | 1 | ā | 4 | 10 | 89.5 (83.2ā93.8) | 21.5 (18.3ā25.0) | 31.1 (27.5ā35.0) | 93.4 (89.2ā96.1) |
Calprotectin POC extended | |||||||||||
āā„2.5Ā % | 97.9 (96.4ā98.9) | 141 | 0 | ā | ā | ā | ā | 100.0 (97.3ā100.0) | 17.8 (15.3ā20.6) | 2.6 (1.4ā4.3) | 100.0 (81.1ā100.0) |
āā„5.0Ā % | 83.6 (80.3ā86.6) | 138 | 3 | ā | ā | 1 | 2 | 97.4 (93.1ā99.2) | 20.3 (17.4ā23.5) | 19.3 (15.8ā23.3) | 97.2 (92.6ā99.2) |
āā„7.5Ā % | 68.5 (64.9ā71.9) | 125 | 16 | 1 | 1 | 5 | 9 | 88.1 (81.5ā92.7) | 22.4 (19.1ā26.1) | 35.6 (31.7ā39.7) | 93.4 (89.6ā96.0) |
Calprotectin ELISA extended | |||||||||||
āā„2.5Ā % | 97.6 (96.0ā98.8) | 141 | 0 | ā | ā | ā | ā | 100.0 (97.3ā100.0) | 17.8 (15.3ā20.7) | 2.9 (1.5ā4.8) | 100.0 (82.7ā100.0) |
āā„5.0Ā % | 84.0 (81.1ā86.6) | 135 | 6 | ā | 1 | 2 | 3 | 96.3 (91.5ā98.7) | 20.0 (17.1ā23.2) | 18.6 (15.5ā22.0) | 96.0 (90.7ā98.6) |
āā„7.5Ā % | 68.1 (64.7ā71.4) | 126 | 15 | ā | 1 | 5 | 9 | 90.0 (83.7ā94.2) | 23.0 (19.7ā26.7) | 36.5 (32.8ā40.4) | 94.5 (91.0ā96.8) |
POC FIT extended | |||||||||||
āā„2.5Ā % | 92.8 (89.0ā96.2) | 140 | 1 | ā | ā | ā | 1 | 99.4 (96.2ā100.0) | 18.6 (16.0ā21.6) | 8.6 (4.5ā13.1) | 98.7 (91.2ā99.9) |
āā„5.0Ā % | 69.9 (64.4ā75.3) | 131 | 10 | 1 | ā | 4 | 5 | 93.0 (87.4ā96.4) | 23.2 (19.6ā27.1) | 34.9 (28.7ā41.4) | 96.0 (92.6ā97.9) |
āā„7.5Ā % | 54.3 (49.6ā59.1) | 124 | 17 | 1 | 4 | 6 | 6 | 88.1 (81.4ā92.8) | 28.2 (24.0ā32.9) | 52.8 (47.4ā58.1) | 95.5 (92.7ā97.2) |
Calprotectin POC and POC FIT extended model | |||||||||||
āā„2.5Ā % | 92.8 (89.4ā95.7) | 141 | 0 | ā | ā | ā | ā | 100.0 (97.3ā100.0) | 18.8 (16.1ā21.8) | 8.7 (5.2ā12.8) | 100.0 (93.4ā100.0) |
āā„5.0Ā % | 69.6 (64.7ā74.3) | 132 | 9 | 1 | ā | 4 | 4 | 93.7 (88.2ā96.8) | 23.5 (19.9ā27.3) | 35.5 (29.9ā41.2) | 96.4 (93.1ā98.2) |
āā„7.5Ā % | 53.3 (48.7ā57.8) | 124 | 17 | 1 | 3 | 7 | 6 | 88.4 (81.7ā93.1) | 28.9 (24.7ā33.5) | 54.1 (49.1ā59.1) | 95.7 (93.1ā97.4) |
Calprotectin ELISA and POC FIT extended model | |||||||||||
āā„2.5Ā % | 92.8 (89.5ā95.6) | 141 | 0 | ā | ā | ā | ā | 100.0 (97.3ā100.0) | 18.8 (16.1ā21.8) | 8.7 (5.3ā12.7) | 100.0 (93.5ā100.0) |
āā„5.0Ā % | 69.0 (64.8ā73.0) | 132 | 9 | 1 | ā | 4 | 4 | 93.3 (87.7ā96.7) | 23.6 (20.2ā27.3) | 36.2 (31.6ā40.9) | 96.3 (93.0ā98.1) |
āā„7.5Ā % | 53.4 (49.2ā57.6) | 124 | 17 | 1 | 2 | 7 | 7 | 87.9 (81.0ā92.7) | 28.7 (24.4ā33.3) | 53.9 (49.2ā58.5) | 95.5 (92.7ā97.3) |